SPECIFIC HBSAG GENETIC-DETERMINANTS ARE ASSOCIATED WITH OCCULT HBV-INFECTION IN VIVO AND HBSAG-DETECTION
2011-01-01 Svicher, V; Cento, V; Bernassola, M; Neumann-Fraune, M; Salpini, R; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spano, A; Ceccherini-Silberstein, F; Verhejen, J; Cappiello, G; Perno, Cf
HBV Evolution and Drug Resistance Emergence in HIV-HBV Co-infected Patients depends upon the Synergistic Interaction between Immunological and Pharmacological Selective Pressure
2010-01-01 Cento, V; Salpini, R; Lo Presti, A; Gori, C; Bertoli, A; Marcuccilli, F; Arlotti, M; Puoti, M; Ladisa, N; Rizzardini, G; Ciccozzi, M; Monforte, Ad; Perno, Cf; Svicher, V
NS3-resistance in advanced HCV patients treated with BOC/TRV-based therapy: impact on virological failure of baseline and early time points
2013-01-01 Cento, V; Di Maio, Vc; Di Paolo, D; Armenia, D; Micheli, V; Tontodonati, M; Antonucci, Fp; Bellocchi, Mc; Bertoli, A; De Leonardis, F; Madeddu, G; Magni, C; Sarrecchia, C; Nosotti, L; Tortora, A; Di Biagio, A; Nicolini, La; Parruti, G; Babudieri, S; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Early detection of NS3-resistance in HCV patients with advanced disease treated with BOC/TVR-based therapy: analysis by population- and ultra-deep sequencing
2013-01-01 Cento, V; Di Maio, Vc; Di Paolo, D; Armenia, D; Micheli, V; Tontodonati, M; Antonucci, Fp; Bellocchi, Mc; Carioti, L; Fortuna, S; Bertoli, A; De Luca, F; De Leonardis, F; Madeddu, G; Navarra, P; Magni, C; Sarrecchia, C; Babudieri, S; Siciliano, M; Parruti, G; Angelico, M; Rizzardini, G; Perno, Cf; Ceccherini-Silberstein, F
Clinical usefulness of HCV sequencing on clinical samples with different HCV-RNA levels
2014-01-01 Ceccherini-Silberstein, F; Di Maio, Vc; Cento, V; Di Paolo, D; Aragri, M; De Leonardis, F; Tontodonati, M; Micheli, V; Antonucci, Fp; Campoli, R; Mancon, A; Bertoli, A; Lenci, I; Cucchiarelli, S; Manunta, A; Di Biagio, A; Sarrecchia, C; Nicolini, La; Marenco, S; Ciotti, M; Nosotti, L; Gianelli, V; Merli, M; Siciliano, M; Landonio, S; De Maria, A; Pellicelli, A; Vecchiet, J; Magni, C; Babudieri, S; Mura, Ms; Taliani, G; Lichtner, M; Maida, I; Vespasiani, U; Romano, M; Morisco, F; Gasbarrini, A; Mastroianni, C; Puoti, M; Mangia, A; Bruno, S; Tisone, G; Caporaso, N; Picciotto, A; Andreoni, M; Parruti, G; Rizzardini, G; Angelico, M; Perno, Cf
Biphasic kinetics of HCV-RNA decay and quasispecies evolution during DAA-treatment are associated with risk of virological failure
2013-01-01 Cento, V; Di Maio, Vc; Valenti, F; Tontodonati, M; Armenia, D; Bellocchi, Mc; Carioti, L; Antonucci, Fp; Trave, F; Cacciatore, P; De Luca, F; Manunta, Af; Bertoli, A; Angelico, M; Pizzigallo, E; Babudieri, S; Parruti, G; Ceccherini-Silberstein, F; Perno, Cf
THE LOWEST X4 GENO2PHENO-FALSE POSITIVE RATE IS ASSOCIATED WITH GREATER CD4-DEPLETION
2011-01-01 Santoro, Mm; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Cento, V; Svicher, V; Bertoli, A; Dori, L; Andreoni, M; Narciso, P; Antinori, A; Ceccherini-Silberstein, F; Perno, Cf
TREATMENT FAILURE TO FIRST-LINE DIRECT ANTIVIRAL (DAA) IN HCV-RELATED ADVANCED LIVER DISEASE: AN ITALIAN REAL-LIFE URBAN SETTING
2016-01-01 Di Paolo, D; Rossi, P; Lenci, I; Milana, M; Masetti, C; Santopaolo, F; Lionetti, R; D'Offizi, G; Pellicelli, A; Fondacaro, L; Siciliano, M; Gerardi, V; Chiesara, F; Moretti, A; Ceccherini-Silberstein, F; Cento, V; Perno, Cf; Angelico, M
Fast and deep early HCV-RNA decay is accompanied by fast aminotransferases normalization values in cirrhotic HCV-1 patients treated with paritaprevir/r-ombitasvir and dasabuvir with ribavirin: a potential role of baseline major resistance mutations
2015-01-01 Cento, V; Teti, E; Biliotti, E; Fiore, F; Antonucci, F; Aragri, M; Magni, Cf; Di Paolo, D; Palazzo, D; La Rosa, Ky; De Luca, F; Sorbo, Mc; Di Maio, Vc; Casalino, P; Sarrecchia, C; Lambiase, L; Gianserra, L; Perinelli, P; Sarmati, L; Gubertini, Ga; Angelico, M; Pasquazzi, C; Andreoni, M; Taliani, G; Perno, Cf; Ceccherini-Silberstein, F
KEY PATTERNS OF HBX AND PRE-S1/S2 MUTATIONS ARE INVOLVED IN MECHANISMS UNDERLYING HBV-INDUCED HEPATOCELLULAR CARCINOMA IN VIVO
2012-01-01 Svicher, V; Mirabelli, C; Cento, V; Salpini, R; Di Maio, Vc; Bertoli, A; Alteri, C; Pollicita, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrechia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Perno, Cf
IN THE ERA OF NEW DIRECT ACTING ANTIVIRAL AGENTS HCV SEQUENCING ALLOWS THE MOST ACCURATE SUBTYPE AND GENOTYPE ASSIGNMENT
2016-01-01 Aragri, M; Di Maio, Vc; Di Paolo, D; Cento, V; De Leonardis, F; Gianserra, L; Tontodonati, M; Micheli, V; Landonio, S; Manunta, A; Bertoli, A; Ciotti, M; Antonucci, Fp; Lenci, I; Francioso, S; Nicolini, La; Marenco, S; Teti, E; Lambiase, L; Milana, M; Maida, I; Di Biagio, A; Pellicelli, A; Nosotti, L; Grieco, S; Cacciatore, P; Romagnoli, D; Siciliano, M; D'Ettorre, G; Babudieri, S; Lichtner, M; Gentilucci, Uv; Romano, M; Sarrecchia, C; Grieco, A; Morisco, F; Mastroianni, C; Vecchiet, J; Puoti, M; D'Amico, E; Gasbarrini, A; Bruno, S; Magni, C; Mura, Ms; Taliani, G; Picciotto, A; Rizzardini, G; Andreoni, M; Pasquazzi, C; Parruti, G; Angelico, M; Perno, Cf; Silberstein, Fc
LOW BURDEN OF DRUG-RESISTANT HBV STRAINS IN ANTI-HBV DRUG-EXPERIENCED AND NAIVE PATIENTS
2011-01-01 Salpini, R; Cento, V; Scopelliti, F; Bertoli, A; Gori, C; Micheli, V; Gubertini, G; De Sanctis, Gm; Sarrecchia, C; Andreoni, M; Angelico, M; Svicher, V; Perno, Cf
OVERLAPPING STRUCTURE OF HBV GENOME AND IMMUNE SELECTING PRESSURE ARE THE MAIN DRIVING FORCES FOR HBV EVOLUTION
2011-01-01 Cento, V; Mirabelli, C; Salpini, R; Han, Y; Mercurio, F; Dimonte, S; Beggel, B; Wittkop, L; Fraune, M; Gori, C; Bertoli, A; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, N; Mazzotta, F; De Sanctis, Gm; Tremulet, P; Angelico, M; Zhang, Xx; Verheyen, J; Silberstein, Fc; Perno, Cf; Svicher, V
Novel patterns of mutations in HBV reverse transcriptase associated with lamivudine resistance in HBV-HIV-coinfected patients
2009-01-01 Svicher, V; Alteri, C; Cento, V; Gori, C; Salpini, R; Marcuccilli, F; Bertoli, A; Arlotti, M; Puoti, M; Ladisa, N; Rizzardini, G; Ceccherini-Silberstein, F; Monforte, Ad; Perno, Cf
NS3 and NS5A genotypes variants correlate with slow or fast progression of HCV-related disease after liver transplantation: does the viral diversity play really a role on fibrosis progression?
2012-01-01 Lenci, I; Cucchiarelli, S; Di Maio, C; Cento, V; Milano, M; Di Paolo, D; De Luca, F; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
CLINICAL RELEVANCE OF NEXT GENERATION SEQUENCING ON BASELINE DETECTION OF MINORITY RESISTANCE ASSOCIATED VARIANTS IN HCV-1 PATIENTS TREATED WITH PROTEASE INHIBITORS
2015-01-01 Armenia, D; Carioti, L; Di Maio, Vc; Bellocchi, Mc; Di Paolo, D; Guerrieri, F; Calvo, L; Cento, V; Tontodonati, M; Micheli, V; De Leonardis, F; Aragri, M; Polilli, E; Manunta, A; Magni, C; Antonucci, Fp; De Luca, F; Sarrecchia, C; Bertoli, A; Lenci, I; Francioso, S; Santoro, Mm; Vecchiet, J; Marenco, S; Picciotto, A; Nosotti, L; Morisco, F; Bruno, S; Puoti, M; Babudieri, S; Mura, Ms; Andreoni, M; Rizzardini, G; Parruti, G; Levrero, M; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
High efficacy of hepatitis C re-treatment strategies after protease inhibitors failure in real-life settings
2016-01-01 Cento, V; Barbaliscia, S; Lenci, I; Ruggiero, T; Masetti, C; Magni, Cf; Micheli, V; Billotti, E; Di Paolo, D; Melis, M; Teti, E; Lambiase, L; Menzaghi, B; Nicolini, La; Marenco, S; Danieli, E; Di Maio, Vc; Aragri, M; Milana, M; Francioso, S; Bertoli, A; Antonucci, F; Esvan, R; Sarmati, L; Sarrecchia, C; Coppola, N; Messina, V; Claar, E; Puoti, M; Ciancio, A; Bonora, S; Babudieri, S; Di Biagio, A; Picciotto, A; Pasquazzi, C; Andreoni, M; Mura, Ms; Taliani, G; Rizzardini, G; Angelico, M; Ceccherini-Silberstein, F; Perno, Cf
A DELAY IN REACHING TIME TO CLINICAL STABLITY FOR HOSPITALISED PATIENTS WITH CAP IS ASSOCIATED WITH FAILURE WITHIN 30 DAYS AFTER HOSPITAL DISCHARGE
2009-01-01 Aliberti, S.; Piffer, F.; Valeria, Betti; Peyrani, P.; Cattaneo, B.; Zanardelli, M.; Salomoni, G.; Blasi, F.; Ramirez, J.
Conversion to extended release tacrolimus in early post lung transplantation period : a pilot study
2018-01-01 Morlacchi, L.; Rossetti, V.; Rosso, L.; Palleschi, A.; Aliberti, S.; Carrinola, R.; Montoli, M.; Nosotti, M.; Tarsia, P.
Timing of previous hospitalizations impacts outcomes in hospitalized patients with CAP
2009-01-01 Ruvolo, L.; Cattaneo, B.; Rossetti, V.; Piffer, F.; Carnevale, C.; Guarize, J.; Katarzyna, Lyskanowska; Aliberti, S.; Tarsia, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| SPECIFIC HBSAG GENETIC-DETERMINANTS ARE ASSOCIATED WITH OCCULT HBV-INFECTION IN VIVO AND HBSAG-DETECTION | 1-gen-2011 | Svicher, V; Cento, V; Bernassola, M; Neumann-Fraune, M; Salpini, R; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spano, A; Ceccherini-Silberstein, F; Verhejen, J; Cappiello, G; Perno, Cf | |
| HBV Evolution and Drug Resistance Emergence in HIV-HBV Co-infected Patients depends upon the Synergistic Interaction between Immunological and Pharmacological Selective Pressure | 1-gen-2010 | Cento, V; Salpini, R; Lo Presti, A; Gori, C; Bertoli, A; Marcuccilli, F; Arlotti, M; Puoti, M; Ladisa, N; Rizzardini, G; Ciccozzi, M; Monforte, Ad; Perno, Cf; Svicher, V | |
| NS3-resistance in advanced HCV patients treated with BOC/TRV-based therapy: impact on virological failure of baseline and early time points | 1-gen-2013 | Cento, V; Di Maio, Vc; Di Paolo, D; Armenia, D; Micheli, V; Tontodonati, M; Antonucci, Fp; Bellocchi, Mc; Bertoli, A; De Leonardis, F; Madeddu, G; Magni, C; Sarrecchia, C; Nosotti, L; Tortora, A; Di Biagio, A; Nicolini, La; Parruti, G; Babudieri, S; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| Early detection of NS3-resistance in HCV patients with advanced disease treated with BOC/TVR-based therapy: analysis by population- and ultra-deep sequencing | 1-gen-2013 | Cento, V; Di Maio, Vc; Di Paolo, D; Armenia, D; Micheli, V; Tontodonati, M; Antonucci, Fp; Bellocchi, Mc; Carioti, L; Fortuna, S; Bertoli, A; De Luca, F; De Leonardis, F; Madeddu, G; Navarra, P; Magni, C; Sarrecchia, C; Babudieri, S; Siciliano, M; Parruti, G; Angelico, M; Rizzardini, G; Perno, Cf; Ceccherini-Silberstein, F | |
| Clinical usefulness of HCV sequencing on clinical samples with different HCV-RNA levels | 1-gen-2014 | Ceccherini-Silberstein, F; Di Maio, Vc; Cento, V; Di Paolo, D; Aragri, M; De Leonardis, F; Tontodonati, M; Micheli, V; Antonucci, Fp; Campoli, R; Mancon, A; Bertoli, A; Lenci, I; Cucchiarelli, S; Manunta, A; Di Biagio, A; Sarrecchia, C; Nicolini, La; Marenco, S; Ciotti, M; Nosotti, L; Gianelli, V; Merli, M; Siciliano, M; Landonio, S; De Maria, A; Pellicelli, A; Vecchiet, J; Magni, C; Babudieri, S; Mura, Ms; Taliani, G; Lichtner, M; Maida, I; Vespasiani, U; Romano, M; Morisco, F; Gasbarrini, A; Mastroianni, C; Puoti, M; Mangia, A; Bruno, S; Tisone, G; Caporaso, N; Picciotto, A; Andreoni, M; Parruti, G; Rizzardini, G; Angelico, M; Perno, Cf | |
| Biphasic kinetics of HCV-RNA decay and quasispecies evolution during DAA-treatment are associated with risk of virological failure | 1-gen-2013 | Cento, V; Di Maio, Vc; Valenti, F; Tontodonati, M; Armenia, D; Bellocchi, Mc; Carioti, L; Antonucci, Fp; Trave, F; Cacciatore, P; De Luca, F; Manunta, Af; Bertoli, A; Angelico, M; Pizzigallo, E; Babudieri, S; Parruti, G; Ceccherini-Silberstein, F; Perno, Cf | |
| THE LOWEST X4 GENO2PHENO-FALSE POSITIVE RATE IS ASSOCIATED WITH GREATER CD4-DEPLETION | 1-gen-2011 | Santoro, Mm; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Cento, V; Svicher, V; Bertoli, A; Dori, L; Andreoni, M; Narciso, P; Antinori, A; Ceccherini-Silberstein, F; Perno, Cf | |
| TREATMENT FAILURE TO FIRST-LINE DIRECT ANTIVIRAL (DAA) IN HCV-RELATED ADVANCED LIVER DISEASE: AN ITALIAN REAL-LIFE URBAN SETTING | 1-gen-2016 | Di Paolo, D; Rossi, P; Lenci, I; Milana, M; Masetti, C; Santopaolo, F; Lionetti, R; D'Offizi, G; Pellicelli, A; Fondacaro, L; Siciliano, M; Gerardi, V; Chiesara, F; Moretti, A; Ceccherini-Silberstein, F; Cento, V; Perno, Cf; Angelico, M | |
| Fast and deep early HCV-RNA decay is accompanied by fast aminotransferases normalization values in cirrhotic HCV-1 patients treated with paritaprevir/r-ombitasvir and dasabuvir with ribavirin: a potential role of baseline major resistance mutations | 1-gen-2015 | Cento, V; Teti, E; Biliotti, E; Fiore, F; Antonucci, F; Aragri, M; Magni, Cf; Di Paolo, D; Palazzo, D; La Rosa, Ky; De Luca, F; Sorbo, Mc; Di Maio, Vc; Casalino, P; Sarrecchia, C; Lambiase, L; Gianserra, L; Perinelli, P; Sarmati, L; Gubertini, Ga; Angelico, M; Pasquazzi, C; Andreoni, M; Taliani, G; Perno, Cf; Ceccherini-Silberstein, F | |
| KEY PATTERNS OF HBX AND PRE-S1/S2 MUTATIONS ARE INVOLVED IN MECHANISMS UNDERLYING HBV-INDUCED HEPATOCELLULAR CARCINOMA IN VIVO | 1-gen-2012 | Svicher, V; Mirabelli, C; Cento, V; Salpini, R; Di Maio, Vc; Bertoli, A; Alteri, C; Pollicita, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrechia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Perno, Cf | |
| IN THE ERA OF NEW DIRECT ACTING ANTIVIRAL AGENTS HCV SEQUENCING ALLOWS THE MOST ACCURATE SUBTYPE AND GENOTYPE ASSIGNMENT | 1-gen-2016 | Aragri, M; Di Maio, Vc; Di Paolo, D; Cento, V; De Leonardis, F; Gianserra, L; Tontodonati, M; Micheli, V; Landonio, S; Manunta, A; Bertoli, A; Ciotti, M; Antonucci, Fp; Lenci, I; Francioso, S; Nicolini, La; Marenco, S; Teti, E; Lambiase, L; Milana, M; Maida, I; Di Biagio, A; Pellicelli, A; Nosotti, L; Grieco, S; Cacciatore, P; Romagnoli, D; Siciliano, M; D'Ettorre, G; Babudieri, S; Lichtner, M; Gentilucci, Uv; Romano, M; Sarrecchia, C; Grieco, A; Morisco, F; Mastroianni, C; Vecchiet, J; Puoti, M; D'Amico, E; Gasbarrini, A; Bruno, S; Magni, C; Mura, Ms; Taliani, G; Picciotto, A; Rizzardini, G; Andreoni, M; Pasquazzi, C; Parruti, G; Angelico, M; Perno, Cf; Silberstein, Fc | |
| LOW BURDEN OF DRUG-RESISTANT HBV STRAINS IN ANTI-HBV DRUG-EXPERIENCED AND NAIVE PATIENTS | 1-gen-2011 | Salpini, R; Cento, V; Scopelliti, F; Bertoli, A; Gori, C; Micheli, V; Gubertini, G; De Sanctis, Gm; Sarrecchia, C; Andreoni, M; Angelico, M; Svicher, V; Perno, Cf | |
| OVERLAPPING STRUCTURE OF HBV GENOME AND IMMUNE SELECTING PRESSURE ARE THE MAIN DRIVING FORCES FOR HBV EVOLUTION | 1-gen-2011 | Cento, V; Mirabelli, C; Salpini, R; Han, Y; Mercurio, F; Dimonte, S; Beggel, B; Wittkop, L; Fraune, M; Gori, C; Bertoli, A; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, N; Mazzotta, F; De Sanctis, Gm; Tremulet, P; Angelico, M; Zhang, Xx; Verheyen, J; Silberstein, Fc; Perno, Cf; Svicher, V | |
| Novel patterns of mutations in HBV reverse transcriptase associated with lamivudine resistance in HBV-HIV-coinfected patients | 1-gen-2009 | Svicher, V; Alteri, C; Cento, V; Gori, C; Salpini, R; Marcuccilli, F; Bertoli, A; Arlotti, M; Puoti, M; Ladisa, N; Rizzardini, G; Ceccherini-Silberstein, F; Monforte, Ad; Perno, Cf | |
| NS3 and NS5A genotypes variants correlate with slow or fast progression of HCV-related disease after liver transplantation: does the viral diversity play really a role on fibrosis progression? | 1-gen-2012 | Lenci, I; Cucchiarelli, S; Di Maio, C; Cento, V; Milano, M; Di Paolo, D; De Luca, F; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| CLINICAL RELEVANCE OF NEXT GENERATION SEQUENCING ON BASELINE DETECTION OF MINORITY RESISTANCE ASSOCIATED VARIANTS IN HCV-1 PATIENTS TREATED WITH PROTEASE INHIBITORS | 1-gen-2015 | Armenia, D; Carioti, L; Di Maio, Vc; Bellocchi, Mc; Di Paolo, D; Guerrieri, F; Calvo, L; Cento, V; Tontodonati, M; Micheli, V; De Leonardis, F; Aragri, M; Polilli, E; Manunta, A; Magni, C; Antonucci, Fp; De Luca, F; Sarrecchia, C; Bertoli, A; Lenci, I; Francioso, S; Santoro, Mm; Vecchiet, J; Marenco, S; Picciotto, A; Nosotti, L; Morisco, F; Bruno, S; Puoti, M; Babudieri, S; Mura, Ms; Andreoni, M; Rizzardini, G; Parruti, G; Levrero, M; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| High efficacy of hepatitis C re-treatment strategies after protease inhibitors failure in real-life settings | 1-gen-2016 | Cento, V; Barbaliscia, S; Lenci, I; Ruggiero, T; Masetti, C; Magni, Cf; Micheli, V; Billotti, E; Di Paolo, D; Melis, M; Teti, E; Lambiase, L; Menzaghi, B; Nicolini, La; Marenco, S; Danieli, E; Di Maio, Vc; Aragri, M; Milana, M; Francioso, S; Bertoli, A; Antonucci, F; Esvan, R; Sarmati, L; Sarrecchia, C; Coppola, N; Messina, V; Claar, E; Puoti, M; Ciancio, A; Bonora, S; Babudieri, S; Di Biagio, A; Picciotto, A; Pasquazzi, C; Andreoni, M; Mura, Ms; Taliani, G; Rizzardini, G; Angelico, M; Ceccherini-Silberstein, F; Perno, Cf | |
| A DELAY IN REACHING TIME TO CLINICAL STABLITY FOR HOSPITALISED PATIENTS WITH CAP IS ASSOCIATED WITH FAILURE WITHIN 30 DAYS AFTER HOSPITAL DISCHARGE | 1-gen-2009 | Aliberti, S.; Piffer, F.; Valeria, Betti; Peyrani, P.; Cattaneo, B.; Zanardelli, M.; Salomoni, G.; Blasi, F.; Ramirez, J. | |
| Conversion to extended release tacrolimus in early post lung transplantation period : a pilot study | 1-gen-2018 | Morlacchi, L.; Rossetti, V.; Rosso, L.; Palleschi, A.; Aliberti, S.; Carrinola, R.; Montoli, M.; Nosotti, M.; Tarsia, P. | |
| Timing of previous hospitalizations impacts outcomes in hospitalized patients with CAP | 1-gen-2009 | Ruvolo, L.; Cattaneo, B.; Rossetti, V.; Piffer, F.; Carnevale, C.; Guarize, J.; Katarzyna, Lyskanowska; Aliberti, S.; Tarsia, P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2016
Data di pubblicazione
- 2020 - 2025102
- 2010 - 20191268
- 2000 - 2009534
- 1990 - 1999111
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY121
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...119
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE96
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY58
- ANNALS OF ONCOLOGY55
- JOURNAL OF CLINICAL ONCOLOGY44
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng732
- ita24
- und6
Accesso al fulltext
- no fulltext1963
- reserved51
- open2